• Latest Posts

Get Ready for One of the Biggest New Drug Approvals of the Year

The 10 Biggest Clinical Success Stories of 2016 in European Biotech

Antibody Therapies are here to Revolutionize Dermatology

New Psoriasis Antibody Therapy puts pressure on Best-Seller drug Humira

Danish Pharma enters in the Biologics arena with Antibody Buy-out

British Biotech startup shows 50% improvement in Atopic Dermatitis


Boehringer Ingelheim Gets €540M upfront for the next Potential Antibody Blockbuster

The Best Selling Biologic of All Time now chased by New Phase III Biosimilar

When the Llama met the Lion: Antibodies Unlock Milestone Payment for Skin Disease

France’s 3rd Largest Pharma Company Finally Opens up to Biotech Innovation

Black Friday Ruin as TWO Biotechs Fail in Phase III Trials

Delenex Therapeutics, the Swiss Biotech developing new types of Therapeutic Antibodies